Department of Anesthesiology, National Defense Medical College, Tokorozawa 359-8513, Japan Department of Anesthesiology, Tokyo Medical and Dental University Graduate School, Tokyo 113-8510, Japan Institute of Developmental Biology and Cancer Research, University of Nice Sophia-Antipolis, Centre National de la Recherche Scientifique, Unité mixte de Recherche 6543, Centre Antoine Lacassagne, Nice 06189, France Aging Regulation Research Team, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo 173-0015, Japan.
Pain. 2012 Nov;153(11):2241-2252. doi: 10.1016/j.pain.2012.07.020. Epub 2012 Aug 16.
Extracellular signal-regulated kinase (ERK) plays critical roles in pain plasticity. However, the specific contribution of ERK2 isoforms to pain plasticity is not necessarily elucidated. Here we investigate the function of ERK2 in mouse pain models. We used the Cre-loxP system to cause a conditional, region-specific, genetic deletion of Erk2. To induce recombination in the central nervous system, Erk2-floxed mice were crossed with nestin promoter-driven cre transgenic mice. In the spinal cord of resultant Erk2 conditional knockout (CKO) mice, ERK2 expression was abrogated in neurons and astrocytes, but indistinguishable in microglia compared to controls. Although Erk2 CKO mice showed a normal baseline paw withdrawal threshold to mechanical stimuli, these mice had a reduced nociceptive response following a formalin injection to the hind paw. In a partial sciatic nerve ligation model, Erk2 CKO mice showed partially restored mechanical allodynia compared to control mice. Interestingly, thermal hyperalgesia was indistinguishable between Erk2 CKO and control mice in this model. In contrast to Erk2 CKO mice, mice with a targeted deletion of ERK1 did not exhibit prominent anomalies in these pain models. In Erk2 CKO mice, compensatory hyperphosphorylation of ERK1 was detected in the spinal cord. However, ERK1 did not appear to influence nociceptive processing because the additional inhibition of ERK1 phosphorylation using MEK (MAPK/ERK kinase) inhibitor SL327 did not produce additional changes in formalin-induced spontaneous behaviors in Erk2 CKO mice. Together, these results indicate that ERK2 plays a predominant and/or specific role in pain plasticity, while the contribution of ERK1 is limited.
细胞外信号调节激酶(ERK)在痛觉敏化中发挥关键作用。然而,ERK2 同工型在痛觉敏化中的特定作用尚不清楚。在此,我们研究了 ERK2 在小鼠疼痛模型中的功能。我们使用 Cre-loxP 系统对 Erk2 进行条件性、区域性、基因缺失。为了在中枢神经系统中诱导重组,将 Erk2 基因敲除(CKO)小鼠与巢蛋白启动子驱动的 cre 转基因小鼠交配。在 CKO 小鼠的脊髓中,ERK2 的表达在神经元和星形胶质细胞中被消除,但与对照组相比,小胶质细胞中的 ERK2 表达无明显差异。尽管 Erk2 CKO 小鼠对机械刺激的基础足底撤回阈值正常,但这些小鼠在足底注射福尔马林后,对伤害性反应的减少。在部分坐骨神经结扎模型中,与对照小鼠相比,Erk2 CKO 小鼠的机械性痛觉过敏部分恢复。有趣的是,在这种模型中,ERK2 CKO 和对照小鼠的热痛觉过敏无明显差异。与 Erk2 CKO 小鼠不同,ERK1 靶向缺失的小鼠在这些疼痛模型中没有表现出明显的异常。在 Erk2 CKO 小鼠中,脊髓中检测到 ERK1 的代偿性过度磷酸化。然而,ERK1 似乎不会影响伤害性处理,因为使用 MEK(MAPK/ERK 激酶)抑制剂 SL327 进一步抑制 ERK1 磷酸化,在 Erk2 CKO 小鼠的福尔马林诱导的自发性行为中没有产生额外的变化。综上所述,这些结果表明 ERK2 在痛觉敏化中发挥主要和/或特异性作用,而 ERK1 的作用有限。